References in periodicals archive ?
Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders.
Because of the complex nature of cancer care, collaboration with the adolescent's oncologist is highly recommended," according to the opinion, which outlines options for prophylactic menstrual suppression (combined hormonal contraceptives, progestin-only therapy, and gonadotropin-releasing hormone agonists) and emergent treatment of acute uterine bleeding (hormonal therapy, antifibrinolytics, and surgical options for patients who fail medical therapy).
Comparison of preovulatory follicular concentrations of epidermal growth factor, insulin-like growth factor-I, and inhibins A and B in women undergoing assisted conception treatment with gonadotropin-releasing hormone (GnRH) agonists and GnRH antagonists.
Efstathiou of Harvard Medical School, Boston, has no association with companies that make gonadotropin-releasing hormone (GnRH) agonists.
Gonadotropin-releasing hormone agonists may be effective, but troublesome anti-estrogenic side effects limit their utility.
GONADOTROPIN-RELEASING HORMONE AND ESTROGENS In men and nonpregnant women, gonadotropin-releasing hormone causes a threefold increase in the serum concentrations of hCG, whereas treatment with estrogen and progestagen lowers the serum hCG by ~50%.
This European Phase 2 study compares three doses of double-blinded Proellex against open label Lucrin, a gonadotropin-releasing hormone (GnRH) agonist, for up to six months of treatment.
The company's three late-stage clinical programs are: elagolix, a gonadotropin-releasing hormone antagonist for women's health that is partnered with AbbVie Inc.
According to the companies, Triptodur, a gonadotropin-releasing hormone (GnRH) agonist administered through intramuscular injection (IM), is the first GnRH agonist to offer once-every six-month dosing approved for the treatment of CPP in the US.
Warnock said that gonadotropin-releasing hormone (GnRH) agonists will decrease estrogen and increase the risk of headaches, including migraines, and increase the risk for depressive symptoms.
Gonadotropin-releasing hormone (GnRH) controls the production of gonadotropins, thereby having an orchestrating effect on the reproductive hormone cascade and spermatogenesis (1).

Full browser ?